GIPM
TMCI icon

G2 Investment Partners Management’s Treace Medical Concepts TMCI Stock Holding History

G2 Investment Partners Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,000
Closed -$506K – 111
2022
Q4 		$506K Sell
22,000
-33,000
-60% -$760K 0.15% 64
2022
Q3 		$1.21M Buy
+55,000
New +$1.06M 0.38% 60

Other funds holding TMCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

G2 Investment Partners Management's TMCI Position: Q1 2023 in Review

G2 Investment Partners Management sold out of Treace Medical Concepts (TMCI) in Q1 2023, closing a stake of 22,000 shares — an estimated $506K sold.

G2 Investment Partners Management first reported a position in TMCI in Q3 2022 and held it in 2 quarters. The position peaked at $1.21M in Q3 2022. 123 funds tracked by Wall St. Rank hold TMCI as of Q1 2023.

  • G2 Investment Partners Management reported no remaining Treace Medical Concepts position as of Q1 2023 after selling out during the quarter.
  • G2 Investment Partners Management sold 22,000 Treace Medical Concepts shares in Q1 2023, an estimated $506K.
  • G2 Investment Partners Management first reported a position in Treace Medical Concepts in Q3 2022 and held it in 2 quarters.
  • G2 Investment Partners Management's Treace Medical Concepts position peaked at $1.21M in Q3 2022.
  • 123 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2023.

Based on G2 Investment Partners Management's 13F filing for Q1 2023, filed 15 May 2023.